Three things to know:
1. Hyalofast is a HA-based scaffold for hyaline-like cartilage regeneration used to treat cartilage injuries and defects.
2. Hyalofast is enrolling patients in its global FastTRACK phase III trial and awaiting regulatory submission in the U.S.
3. Anika will also be showcasing its entire regenerative medicine and orthobiologics line at the ICRS Focus Meeting.
“Hyalofast represents a remarkable advance in supporting cartilage regrowth using a convenient, one-step, minimally invasive procedure that can be tailored to each individual patient’s needs,” said Joseph Darling, president and CEO of Anika Therapeutics.
More articles on surface technology:
4 key updates in surface technology for spine
Alphatec launches new titanium interbody implant for spine – 3 insights
Camber Spine technology reaches 2,000 spinal level implantations, 100% surgeon user growth
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
